Skip to main content
. 2021 Feb 18;53(1):13–28. doi: 10.3947/ic.2020.0136

Table 1. Meta-analysis for the association among comorbidities and critical conditions among COVID-19 patients.

Severe infection ICU admission ARDS Cardiac injury Liver injury Overall critical condition
N (I2) RR (95% CI) N (I2) RR (95% CI) N (I2) RR (95% CI) N (I2) RR (95% CI) N (I2) RR (95% CI) N (I2) RR (95% CI)
COPD 10 (0%) 3.97 (2.77 - 5.69) 4 (0%) 4.76 (2.44 - 9.27) 1 (NA) 3.00 (0.15 - 61.7) 2 (0%) 4.87 (1.79 - 13.3) 1 (NA) 11.0 (0.58 - 207) 18 (0%) 4.22 (3.12 - 5.69)
CVD 9 (29.6%) 3.15 (2.34 - 4.25) 4 (0%) 2.59 (1.61 - 4.16) 2 (0%) 2.51 (0.80 - 7.87) 2 (57.2%) 4.30 (2.56 - 7.20) 2 (0%) 0.90 (0.27 - 2.95) 19 (15.7%) 3.00 (2.41 - 3.73)
CVA 5 (0%) 2.72 (1.84 - 4.02) 1 (NA) 10.7 (1.06 - 108) 6 (0%) 2.86 (1.95 - 4.19)
Hypertension 13 (49.8%) 1.90 (1.68 - 2.16) 4 (1.9%) 2.64 (2.03 - 3.44) 3 (0%) 1.72 (1.10 - 2.68) 2 (0%) 2.51 (1.93 - 3.26) 2 (2.3%) 1.00 (0.42 - 2.37) 24 (42.2%) 2.02 (1.82 - 2.23)
Diabetes 13 (51.1%) 2.01 (1.70 - 2.39) 4 (44.5%) 2.44 (1.66 - 3.60) 3 (0%) 3.35 (1.70 - 6.59) 2 (0%) 2.04 (1.27 - 3.27) 2 (0%) 1.06 (0.31 - 3.64) 24 (32.3%) 2.10 (1.82 - 2.43)
Chronic liver disease 8 (29.1%) 1.10 (0.71 - 1.70) 3 (0%) 0.50 (0.12 - 2.06) 1 (NA) 4.07 (0.58 - 28.5) 12 (17.8%) 1.05 (0.70 - 1.58)
Chronic kidney disease 7 (0%) 2.09 (1.33 - 3.28) 3 (0%) 1.56 (0.47 - 5.12) 1 (NA) 1.00 (0.08 - 12.6) 1 (NA) 2.26 (0.78 - 6.57) 12 (0%) 2.00 (1.36 - 2.94)
Malignancy 9 (8.0%) 2.45 (1.67 - 3.58) 4 (31.5%) 2.26 (1.27 - 4.01) 1 (NA) 32.2 (4.28 - 241) 1 (NA) 14.3 (3.02 - 67.4) 15 (37.7%) 2.91 (2.16 - 3.91)

COVID-19, coronavirus disease 2019; ICU, intensive care unit; ARDS, acute respiratory distress syndrome; N, number of studies; RR, relative risk; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; CVA, cerebrovascular accident; NA, not applicable.